Junxiang Li

750 total citations
44 papers, 565 citations indexed

About

Junxiang Li is a scholar working on Surgery, Epidemiology and Molecular Biology. According to data from OpenAlex, Junxiang Li has authored 44 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 14 papers in Epidemiology and 13 papers in Molecular Biology. Recurrent topics in Junxiang Li's work include Liver Disease Diagnosis and Treatment (11 papers), Gastroesophageal reflux and treatments (9 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). Junxiang Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Gastroesophageal reflux and treatments (9 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). Junxiang Li collaborates with scholars based in China, Japan and United Kingdom. Junxiang Li's co-authors include Tangyou Mao, Yunliang Wang, Xiang Tan, Yi Dai, Yuan Cheng, Wenfu Tang, Jiali Liu, Zhongmei Sun, Xiaohong Li and Hui Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Junxiang Li

42 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junxiang Li China 15 198 166 132 118 75 44 565
Jiayin Yao China 12 126 0.6× 107 0.6× 128 1.0× 38 0.3× 63 0.8× 32 466
Kazunari Kanke Japan 8 146 0.7× 193 1.2× 148 1.1× 113 1.0× 71 0.9× 21 801
Natalia Lajczak Ireland 9 318 1.6× 162 1.0× 92 0.7× 73 0.6× 32 0.4× 13 583
Chung Hong Kong 18 305 1.5× 336 2.0× 52 0.4× 152 1.3× 61 0.8× 53 936
Kazuhisa Hirayama Japan 6 126 0.6× 78 0.5× 135 1.0× 50 0.4× 71 0.9× 18 611
Zhipeng Tang China 14 245 1.2× 83 0.5× 125 0.9× 53 0.4× 92 1.2× 31 586
Chenyang Li China 12 195 1.0× 55 0.3× 78 0.6× 29 0.2× 47 0.6× 25 521
Konstantinos J. Dabos United Kingdom 12 93 0.5× 161 1.0× 90 0.7× 110 0.9× 55 0.7× 24 425
Bolin Li China 11 209 1.1× 87 0.5× 111 0.8× 17 0.1× 66 0.9× 51 613

Countries citing papers authored by Junxiang Li

Since Specialization
Citations

This map shows the geographic impact of Junxiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxiang Li more than expected).

Fields of papers citing papers by Junxiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxiang Li. The network helps show where Junxiang Li may publish in the future.

Co-authorship network of co-authors of Junxiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Junxiang Li. A scholar is included among the top collaborators of Junxiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxiang Li. Junxiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pei, Wenjing, Tangyou Mao, Yang Zhang, et al.. (2025). Single-cell RNA-seq reveals the immune profile changes in patients with diarrhoeal-irritable bowel syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(7). 167945–167945.
2.
Sun, Zhongmei, Wenting Wang, Zhibin Wang, et al.. (2024). Combining Metagenomics, Network Pharmacology and RNA-Seq Strategies to Reveal the Therapeutic Effects and Mechanisms of Qingchang Wenzhong Decoction on Inflammatory Bowel Disease in Mice. Drug Design Development and Therapy. Volume 18. 4273–4289. 2 indexed citations
3.
Zhang, Ye, Junxiang Li, Wenji Zhang, et al.. (2024). Novel insights into macrophage immunometabolism in nonalcoholic steatohepatitis. International Immunopharmacology. 131. 111833–111833. 3 indexed citations
4.
5.
Gao, Han, Qiong He, Zhi Pang, et al.. (2022). The Development and Validation of Anti-paratuberculosis-nocardia Polypeptide Antibody [Anti-pTNP] for the Diagnosis of Crohn’s Disease. Journal of Crohn s and Colitis. 16(7). 1110–1123. 3 indexed citations
6.
Li, Feng, Junxiang Li, Runhua Chen, et al.. (2022). Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 3 indexed citations
7.
Cheng, Yuan, et al.. (2022). Network Pharmacology Analysis of Hewei Jiangni Granule for Gastroesophageal Reflux Disease and Experimental Verification of Its Anti-Neurogenic Inflammation Mechanism. Drug Design Development and Therapy. Volume 16. 1349–1363. 3 indexed citations
8.
Jiang, Hui, Tangyou Mao, Zhongmei Sun, et al.. (2022). Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1/Nrf2 signaling pathway and gut microbiota. Frontiers in Microbiology. 13. 1001778–1001778. 15 indexed citations
9.
Tan, Xiang, Wenjing Pei, Zhibin Wang, et al.. (2021). Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 10 indexed citations
10.
11.
Lü, Fang, Ping Wang, Qian Yang, et al.. (2020). Epigastric pain syndrome: What can traditional Chinese medicine do? A randomized controlled trial of Biling Weitong Granules. World Journal of Gastroenterology. 26(28). 4170–4181. 12 indexed citations
12.
Cheng, Yuan, et al.. (2020). Systematic assessment of environmental factors for gastroesophageal reflux disease: An umbrella review of systematic reviews and meta-analyses. Digestive and Liver Disease. 53(5). 566–573. 12 indexed citations
13.
Shu, Weigang, Zhi Pang, Jian Lin, et al.. (2019). Anti-TNF-α Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease. Mediators of Inflammation. 2019. 1–13. 19 indexed citations
14.
Guo, Yi, et al.. (2018). Gegen Qinlian Decoction Attenuates High‐Fat Diet‐Induced Steatohepatitis in Rats via Gut Microbiota. Evidence-based Complementary and Alternative Medicine. 2018(1). 7370891–7370891. 25 indexed citations
15.
Guo, Yi, Junxiang Li, Yunliang Wang, et al.. (2017). Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2017(1). 6178358–6178358. 20 indexed citations
16.
17.
Li, Junxiang, Ying Ma, Qian Guan, et al.. (2014). Transcriptional Profiling Reveals Crosstalk Between Mesenchymal Stem Cells and Endothelial Cells Promoting Prevascularization by Reciprocal Mechanisms. Stem Cells and Development. 24(5). 610–623. 17 indexed citations
18.
Niu, Hai, et al.. (2014). Robinetinidol-flavone attenuates cholesterol synthesis in hepatoma cells via inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Molecular Medicine Reports. 11(1). 561–566. 4 indexed citations
19.
Li, Junxiang. (2013). Influences of modified Banxia Xiexin Tang on symptoms and quality of life in patients with non-erosive reflux disease. Journal of Beijing University of Traditional Chinese Medicine. 1 indexed citations
20.
Li, Junxiang. (2011). Influences of Jianpi Shugan Fang on ADP and TNF-α in rats with non-alcoholic steatohepatitis. Journal of Beijing University of Traditional Chinese Medicine. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiayin Yao Breakdown of academic impact, for papers by Kazunari Kanke Breakdown of academic impact, for papers by Natalia Lajczak Breakdown of academic impact, for papers by Chung Breakdown of academic impact, for papers by Kazuhisa Hirayama Breakdown of academic impact, for papers by Zhipeng Tang Breakdown of academic impact, for papers by Chenyang Li Breakdown of academic impact, for papers by Konstantinos J. Dabos Breakdown of academic impact, for papers by Bolin Li
Rankless by CCL
2026